References
- http://www.bokjiro.go.kr/nwel/welfareinfo/livwelnews/news/retireveNewsDetail.do?boardSid=308&dataSid=6215507
- J. A. Farina Jr, C. E. Piccinato, A. D. Camppos, and M. A. Rossi, "Comparative study of isovolemic hemodilution with 3% albumin, dextran-40, and prophylactic enoxaparin (LMWH) on thrombus formation at venous microanastomosis in rats," Microsurgery, Vol.26, No.6, pp.456-466, 2006. https://doi.org/10.1002/micr.20270
- K. Gombocz, A. Beledi, N. Alotti, G. Kecskes, V. Gabor, L. Bogar, T. Koszegi, and J. Garai, "Influence of dextran-70 on systemic inflammatory response and myocardial ischemia-reperfusion following cardiac operations," Crit Care, Vol.11, No.4, p.R87, 2007. https://doi.org/10.1186/cc6095
- KFDA, 2006 Drug reevaluate major cases. Available from: http://www.ikwn.co.kr/bbs/list.html
- L. Jaemin, "Plasma volume expanders and intraoperative fluid therapy," Korean J Anesthesiol, Vol.56, No.5, pp.483-491, 2009. https://doi.org/10.4097/kjae.2009.56.5.483
- Drug Administration Protocol-Dextran 40 (Rheomacrodex), Liverpool Health Service Intensive Care Unit, First Issued December 2002.
- G. Biesenbach, W. Kaiser, and J. Zazgornik, "Incidence of acute oligoanuric renal failure in dextran 40 treated patients with acute ischemic stroke stage III or IV," Ren Fail, Vol.19, No.1, pp.69-75, 1997. https://doi.org/10.3109/08860229709026261
- A. P. Bhatt, V. T. Neppalli, E. A. Kelley, A. J. Schlueter, and C. P. Thomas, "Dextran Removal by Plasmapheresis in a Kidney-Pancreas Transplant Recipient With Dextran 40-Induced Osmotic Nephrosis," Am J Kidney Dis, Vol.57, No.4, pp.621-623, 2011. https://doi.org/10.1053/j.ajkd.2010.10.057
- C. E. Zinderman, L. Landow, and R. P. Wise, "Anaphylactoid reactions to Dextran 40 and 70: Reports to the United States Food and Drug Administration, 1969 to 2004," Journal of Vascular Surgery, Vol.43, No.5, pp.1004-1009, 2006. https://doi.org/10.1016/j.jvs.2006.01.006
- E. C. Davies, C. F. Green, S. Tayler, P. R. Williamson, D. R. Mottram, and M. Pirmohamed, "Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patients-episodes," PLoS One, Vol.4, No.e4439, 2009.
- K. G. Ljungstrom, H. Renck, K. Stanberg, H. Hedin, W. Richter, and E. Wirdelov, "Adverse reactions to dextran in Sweden," Acta Chir Scand, Vol.149, pp.256-62, 1983.
- Y. A. Do and S. H. Lee, "Adverse drug reactions with oseltamivir treatment in the South Korea outbreak of 2009 pandemic influenza A(H1N1), Kor J Clin Pharm, Vol.21, No.4, pp.353-363, 2009.
- H. Kawano, K. Nomura, S. Kawahito, N. Ohshita, K. Tanaka, and S. Oshita, "Dextran-induced anaphylactic shock during general anesthesia: a case repor," Masui, Vol.61, No.11, pp.1265-8, 2012
- KIMS. dextran. Available from: http://www.kimsonline.co.kr./131_UnifiedSearch/DrugSearchList.aspx?src=header&PageSearch=T&PageWord=dextran(Last accessed on February 15, 2013).
- K. S. Lee, M. H. Kong, S. H. Chang, H. Cho, H. J. Lim, and N. S. Kim, "A Case Report of Anaphylactoid Reaction to Dextran 40," Korea Journal of Anesthesiology, Vol.27, No.12, 1822-26, 1994. https://doi.org/10.4097/kjae.1994.27.12.1822
- S. H. Cho, "Hypersensitivity Reaction," BioWave, Vol.7, No.3, 2005.
- J. Lazarou, B. H. Pomeranz, and P. N. Corey, "Incidence of adverse drug reactions in hospitalized patients: a meter-analysis of prospective studies," JAMA, Vol.279, No.15, pp.1200-1205, 1998. https://doi.org/10.1001/jama.279.15.1200
- K. G. Ljungstrom, B. Willam, and H. Heidin, "Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveillance of dextran 1," Ann Fr Anesth Reanim, Vol.12, No.2, pp.19-22, 1993. https://doi.org/10.1016/S0750-7658(16)30019-3